mano has published 9 books. His newest book,
Staying Power: Six Enduring Principles for Managing Strategy and Innovation in an Uncertain World (2010), is based on the 2009 Clarendon Lectures in Management Studies at Oxford University and is translated into Japanese, Chinese, and Italian.
The Business of Software (2004) was named one of the best business books of the year by Steve Lohr of The New York Times and is translated into Japanese and Chinese.
Microsoft Secrets (1995, with Richard Selby) is a best-selling study of Microsoft's strategy, organization, and approach to software development, and has sold some 150,000 copies in 14 languages.
Platform Leadership: How Intel, Microsoft, and Cisco Drive Industry Innovation (2002, with Annabelle Gawer) examines how industry leaders orchestrate complementary innovations that make their platforms more valuable.
Competing on Internet Time: Lessons from Netscape and its Battle with Microsoft (1998, with David Yoffie), was named one of the top 10 business books of 1998 by
Business Week and Amazon.com, and played a central role in the Microsoft anti-trust trial.
Thinking Beyond Lean: How Multi-Project Management is Transforming Product Development at Toyota and Other Companies (1998, with Kentaro Nobeoka) analyzes product development and platform strategies in the auto industry. He is also co-editor of
Strategic Thinking for the Next Economy (2001, with Costas Markides) and author of
Japan's Software Factories: A Challenge to U.S. Management (1991) and
The Japanese Automobile Industry: Technology and Management at Nissan and Toyota (1985).
About Quantum Leap Innovations:
Quantum Leap Innovations, Inc. is the creator of the Quantum Leap® Pattern Based Analytics family of products which includes Pattern Based Discovery, Pattern Based Prediction, and Pattern Based Reasoning. Pattern Based Analytics is a powerful new approach to data analysis
'/>"/>
SOURCE Quantum Leap Innovations Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer2.
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer3.
Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board4.
Netsmart Technologies Names Michael Valentine as Chief Executive Officer5.
BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board6.
Michael J. Fox Foundation Awards Grant to Zymes LLC7.
Dr. Michael Hanley Joins Celtaxsys as CEO8.
NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease9.
Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO10.
Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)11.
Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation